Maryland Technology Development Corporation - Long COVID Innovation Grant and Loan Program
Hearing (Senate)
Email me when SB 392 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track SB 392. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill would have the Maryland Technology Development Corporation set up a fund and a grant‑loan program to support state‑based research, product development, and manufacturing aimed at treating Long COVID. An independent scientific review committee would evaluate proposals, and the corporation would award and oversee the money. The measure failed to pass.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about SB 392
3 free questions a day, no accountHearings
- Finance — Bill HearingFinance · Feb 12, 2026
History
- Hearing 2/12 at 1:00 p.m.
- First Reading Finance
Sponsors
- King · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when SB 392 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 392 freeOr ask your AI assistant about SB 392 directly:
Add to Claude, ChatGPT or Cursor